Metabolic Diseases  >>  AZD8329  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AZD8329 / AstraZeneca
NCT01225939: A Study Conducted Over 3 Periods to Look at the Drug in the Body

Completed
1
18
Europe
AZD8329
AstraZeneca
Type 2 Diabetes Mellitus
12/10
12/10

Download Options